IBDEI0ES ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36997,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,36997,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,36998,0)
 ;;=N50.811^^107^1484^109
 ;;^UTILITY(U,$J,358.3,36998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36998,1,3,0)
 ;;=3^Testicular Pain,Right Side
 ;;^UTILITY(U,$J,358.3,36998,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,36998,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,36999,0)
 ;;=N35.919^^107^1484^114
 ;;^UTILITY(U,$J,358.3,36999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36999,1,3,0)
 ;;=3^Urethral Stricture,NOS,Male
 ;;^UTILITY(U,$J,358.3,36999,1,4,0)
 ;;=4^N35.919
 ;;^UTILITY(U,$J,358.3,36999,2)
 ;;=^5157412
 ;;^UTILITY(U,$J,358.3,37000,0)
 ;;=N35.92^^107^1484^113
 ;;^UTILITY(U,$J,358.3,37000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37000,1,3,0)
 ;;=3^Urethral Stricture,NOS,Female
 ;;^UTILITY(U,$J,358.3,37000,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,37000,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,37001,0)
 ;;=R82.81^^107^1484^101
 ;;^UTILITY(U,$J,358.3,37001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37001,1,3,0)
 ;;=3^Pyuria
 ;;^UTILITY(U,$J,358.3,37001,1,4,0)
 ;;=4^R82.81
 ;;^UTILITY(U,$J,358.3,37001,2)
 ;;=^101879
 ;;^UTILITY(U,$J,358.3,37002,0)
 ;;=N18.30^^107^1484^17
 ;;^UTILITY(U,$J,358.3,37002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37002,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3 Unspec
 ;;^UTILITY(U,$J,358.3,37002,1,4,0)
 ;;=4^N18.30
 ;;^UTILITY(U,$J,358.3,37002,2)
 ;;=^5159286
 ;;^UTILITY(U,$J,358.3,37003,0)
 ;;=N18.31^^107^1484^18
 ;;^UTILITY(U,$J,358.3,37003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37003,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3a
 ;;^UTILITY(U,$J,358.3,37003,1,4,0)
 ;;=4^N18.31
 ;;^UTILITY(U,$J,358.3,37003,2)
 ;;=^5159287
 ;;^UTILITY(U,$J,358.3,37004,0)
 ;;=N18.32^^107^1484^19
 ;;^UTILITY(U,$J,358.3,37004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37004,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3b
 ;;^UTILITY(U,$J,358.3,37004,1,4,0)
 ;;=4^N18.32
 ;;^UTILITY(U,$J,358.3,37004,2)
 ;;=^5159288
 ;;^UTILITY(U,$J,358.3,37005,0)
 ;;=G44.1^^107^1485^10
 ;;^UTILITY(U,$J,358.3,37005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37005,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,37005,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,37005,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,37006,0)
 ;;=G43.909^^107^1485^6
 ;;^UTILITY(U,$J,358.3,37006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37006,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,37006,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,37006,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,37007,0)
 ;;=G44.009^^107^1485^1
 ;;^UTILITY(U,$J,358.3,37007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37007,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,37007,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,37007,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,37008,0)
 ;;=G44.40^^107^1485^5
 ;;^UTILITY(U,$J,358.3,37008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37008,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,37008,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,37008,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,37009,0)
 ;;=G44.89^^107^1485^2
 ;;^UTILITY(U,$J,358.3,37009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37009,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,37009,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,37009,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,37010,0)
 ;;=G44.84^^107^1485^8
 ;;^UTILITY(U,$J,358.3,37010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37010,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,37010,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,37010,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,37011,0)
 ;;=G44.301^^107^1485^7
 ;;^UTILITY(U,$J,358.3,37011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37011,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,37011,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,37011,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,37012,0)
 ;;=G44.209^^107^1485^9
 ;;^UTILITY(U,$J,358.3,37012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37012,1,3,0)
 ;;=3^Tension-Type Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,37012,1,4,0)
 ;;=4^G44.209
 ;;^UTILITY(U,$J,358.3,37012,2)
 ;;=^5003936
 ;;^UTILITY(U,$J,358.3,37013,0)
 ;;=R51.0^^107^1485^3
 ;;^UTILITY(U,$J,358.3,37013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37013,1,3,0)
 ;;=3^Headache w/ Orthostatic Component,NEC
 ;;^UTILITY(U,$J,358.3,37013,1,4,0)
 ;;=4^R51.0
 ;;^UTILITY(U,$J,358.3,37013,2)
 ;;=^5159305
 ;;^UTILITY(U,$J,358.3,37014,0)
 ;;=R51.9^^107^1485^4
 ;;^UTILITY(U,$J,358.3,37014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37014,1,3,0)
 ;;=3^Headache,Unspec
 ;;^UTILITY(U,$J,358.3,37014,1,4,0)
 ;;=4^R51.9
 ;;^UTILITY(U,$J,358.3,37014,2)
 ;;=^5159306
 ;;^UTILITY(U,$J,358.3,37015,0)
 ;;=I30.0^^107^1486^5
 ;;^UTILITY(U,$J,358.3,37015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37015,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,37015,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,37015,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,37016,0)
 ;;=I34.8^^107^1486^6
 ;;^UTILITY(U,$J,358.3,37016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37016,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
 ;;^UTILITY(U,$J,358.3,37016,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,37016,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,37017,0)
 ;;=I34.0^^107^1486^13
 ;;^UTILITY(U,$J,358.3,37017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37017,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,37017,1,4,0)
 ;;=4^I34.0
 ;;^UTILITY(U,$J,358.3,37017,2)
 ;;=^5007169
 ;;^UTILITY(U,$J,358.3,37018,0)
 ;;=I34.9^^107^1486^12
 ;;^UTILITY(U,$J,358.3,37018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37018,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,37018,1,4,0)
 ;;=4^I34.9
 ;;^UTILITY(U,$J,358.3,37018,2)
 ;;=^5007173
 ;;^UTILITY(U,$J,358.3,37019,0)
 ;;=I34.2^^107^1486^7
 ;;^UTILITY(U,$J,358.3,37019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37019,1,3,0)
 ;;=3^Nonrhematic Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,37019,1,4,0)
 ;;=4^I34.2
 ;;^UTILITY(U,$J,358.3,37019,2)
 ;;=^5007171
 ;;^UTILITY(U,$J,358.3,37020,0)
 ;;=I35.0^^107^1486^10
 ;;^UTILITY(U,$J,358.3,37020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37020,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,37020,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,37020,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,37021,0)
 ;;=I35.1^^107^1486^9
 ;;^UTILITY(U,$J,358.3,37021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37021,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,37021,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,37021,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,37022,0)
 ;;=I35.2^^107^1486^11
 ;;^UTILITY(U,$J,358.3,37022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37022,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,37022,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,37022,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,37023,0)
 ;;=I35.9^^107^1486^8
 ;;^UTILITY(U,$J,358.3,37023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37023,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,37023,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,37023,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,37024,0)
 ;;=I38.^^107^1486^4
 ;;^UTILITY(U,$J,358.3,37024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37024,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,37024,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,37024,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,37025,0)
 ;;=I05.0^^107^1486^18
 ;;^UTILITY(U,$J,358.3,37025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37025,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,37025,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,37025,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,37026,0)
 ;;=I05.8^^107^1486^19
 ;;^UTILITY(U,$J,358.3,37026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37026,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,37026,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,37026,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,37027,0)
 ;;=I05.9^^107^1486^20
 ;;^UTILITY(U,$J,358.3,37027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37027,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,37027,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,37027,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,37028,0)
 ;;=I07.1^^107^1486^21
 ;;^UTILITY(U,$J,358.3,37028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37028,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,37028,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,37028,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,37029,0)
 ;;=I07.9^^107^1486^22
 ;;^UTILITY(U,$J,358.3,37029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37029,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,37029,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,37029,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,37030,0)
 ;;=I08.0^^107^1486^16
 ;;^UTILITY(U,$J,358.3,37030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37030,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,37030,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,37030,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,37031,0)
 ;;=I09.89^^107^1486^17
 ;;^UTILITY(U,$J,358.3,37031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37031,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,37031,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,37031,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,37032,0)
 ;;=I47.1^^107^1486^24
 ;;^UTILITY(U,$J,358.3,37032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37032,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,37032,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,37032,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,37033,0)
 ;;=I48.0^^107^1486^15
 ;;^UTILITY(U,$J,358.3,37033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37033,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,37033,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,37033,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,37034,0)
 ;;=I49.5^^107^1486^23
 ;;^UTILITY(U,$J,358.3,37034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37034,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,37034,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,37034,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,37035,0)
 ;;=I49.8^^107^1486^3
 ;;^UTILITY(U,$J,358.3,37035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37035,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,37035,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,37035,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,37036,0)
 ;;=I49.9^^107^1486^2
 ;;^UTILITY(U,$J,358.3,37036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37036,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,37036,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,37036,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,37037,0)
 ;;=R00.1^^107^1486^1
 ;;^UTILITY(U,$J,358.3,37037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37037,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,37037,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,37037,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,37038,0)
 ;;=I34.1^^107^1486^14
 ;;^UTILITY(U,$J,358.3,37038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37038,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,37038,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,37038,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,37039,0)
 ;;=D68.4^^107^1487^1
 ;;^UTILITY(U,$J,358.3,37039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37039,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,37039,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,37039,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,37040,0)
 ;;=D59.9^^107^1487^2
 ;;^UTILITY(U,$J,358.3,37040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37040,1,3,0)
 ;;=3^Acquired Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,37040,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,37040,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,37041,0)
 ;;=C91.00^^107^1487^5
 ;;^UTILITY(U,$J,358.3,37041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37041,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,37041,1,4,0)
 ;;=4^C91.00
 ;;^UTILITY(U,$J,358.3,37041,2)
 ;;=^5001762
 ;;^UTILITY(U,$J,358.3,37042,0)
 ;;=C91.01^^107^1487^4
 ;;^UTILITY(U,$J,358.3,37042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37042,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,37042,1,4,0)
 ;;=4^C91.01
 ;;^UTILITY(U,$J,358.3,37042,2)
 ;;=^5001763
 ;;^UTILITY(U,$J,358.3,37043,0)
 ;;=C92.01^^107^1487^7
 ;;^UTILITY(U,$J,358.3,37043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37043,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,37043,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,37043,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,37044,0)
 ;;=C92.00^^107^1487^8
 ;;^UTILITY(U,$J,358.3,37044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37044,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,37044,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,37044,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,37045,0)
 ;;=C92.61^^107^1487^9
 ;;^UTILITY(U,$J,358.3,37045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37045,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
 ;;^UTILITY(U,$J,358.3,37045,1,4,0)
 ;;=4^C92.61
 ;;^UTILITY(U,$J,358.3,37045,2)
 ;;=^5001808
 ;;^UTILITY(U,$J,358.3,37046,0)
 ;;=C92.60^^107^1487^10
 ;;^UTILITY(U,$J,358.3,37046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37046,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
 ;;^UTILITY(U,$J,358.3,37046,1,4,0)
 ;;=4^C92.60
 ;;^UTILITY(U,$J,358.3,37046,2)
 ;;=^5001807
 ;;^UTILITY(U,$J,358.3,37047,0)
 ;;=C92.A1^^107^1487^11
 ;;^UTILITY(U,$J,358.3,37047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37047,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
 ;;^UTILITY(U,$J,358.3,37047,1,4,0)
 ;;=4^C92.A1
 ;;^UTILITY(U,$J,358.3,37047,2)
 ;;=^5001814
 ;;^UTILITY(U,$J,358.3,37048,0)
 ;;=C92.A0^^107^1487^12
 ;;^UTILITY(U,$J,358.3,37048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37048,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
 ;;^UTILITY(U,$J,358.3,37048,1,4,0)
 ;;=4^C92.A0
 ;;^UTILITY(U,$J,358.3,37048,2)
 ;;=^5001813
 ;;^UTILITY(U,$J,358.3,37049,0)
 ;;=C92.51^^107^1487^13
 ;;^UTILITY(U,$J,358.3,37049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37049,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,37049,1,4,0)
 ;;=4^C92.51
 ;;^UTILITY(U,$J,358.3,37049,2)
 ;;=^5001805
 ;;^UTILITY(U,$J,358.3,37050,0)
 ;;=C92.50^^107^1487^14
 ;;^UTILITY(U,$J,358.3,37050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37050,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,37050,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,37050,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,37051,0)
 ;;=C94.40^^107^1487^17
 ;;^UTILITY(U,$J,358.3,37051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37051,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
 ;;^UTILITY(U,$J,358.3,37051,1,4,0)
 ;;=4^C94.40
 ;;^UTILITY(U,$J,358.3,37051,2)
 ;;=^5001843
 ;;^UTILITY(U,$J,358.3,37052,0)
 ;;=C94.42^^107^1487^15
 ;;^UTILITY(U,$J,358.3,37052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37052,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,37052,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,37052,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,37053,0)
 ;;=C94.41^^107^1487^16
 ;;^UTILITY(U,$J,358.3,37053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37053,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
 ;;^UTILITY(U,$J,358.3,37053,1,4,0)
 ;;=4^C94.41
 ;;^UTILITY(U,$J,358.3,37053,2)
 ;;=^5001844
 ;;^UTILITY(U,$J,358.3,37054,0)
 ;;=D62.^^107^1487^18
 ;;^UTILITY(U,$J,358.3,37054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37054,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,37054,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,37054,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,37055,0)
 ;;=C92.41^^107^1487^19
 ;;^UTILITY(U,$J,358.3,37055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37055,1,3,0)
 ;;=3^Acute Promyelocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,37055,1,4,0)
 ;;=4^C92.41
 ;;^UTILITY(U,$J,358.3,37055,2)
 ;;=^5001802
 ;;^UTILITY(U,$J,358.3,37056,0)
 ;;=C92.40^^107^1487^20
 ;;^UTILITY(U,$J,358.3,37056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37056,1,3,0)
 ;;=3^Acute Promyelocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,37056,1,4,0)
 ;;=4^C92.40
 ;;^UTILITY(U,$J,358.3,37056,2)
 ;;=^5001801
 ;;^UTILITY(U,$J,358.3,37057,0)
 ;;=D56.0^^107^1487^21
 ;;^UTILITY(U,$J,358.3,37057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37057,1,3,0)
 ;;=3^Alpha Thalassemia
 ;;^UTILITY(U,$J,358.3,37057,1,4,0)
 ;;=4^D56.0
 ;;^UTILITY(U,$J,358.3,37057,2)
 ;;=^340494
 ;;^UTILITY(U,$J,358.3,37058,0)
 ;;=D63.1^^107^1487^23
 ;;^UTILITY(U,$J,358.3,37058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37058,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,37058,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,37058,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,37059,0)
 ;;=D63.0^^107^1487^24
 ;;^UTILITY(U,$J,358.3,37059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37059,1,3,0)
 ;;=3^Anemia in Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,37059,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,37059,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,37060,0)
 ;;=D63.8^^107^1487^22
 ;;^UTILITY(U,$J,358.3,37060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37060,1,3,0)
 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,37060,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,37060,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,37061,0)
 ;;=C22.3^^107^1487^27
 ;;^UTILITY(U,$J,358.3,37061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37061,1,3,0)
 ;;=3^Angiosarcoma of Liver
 ;;^UTILITY(U,$J,358.3,37061,1,4,0)
 ;;=4^C22.3
 ;;^UTILITY(U,$J,358.3,37061,2)
 ;;=^5000936
 ;;^UTILITY(U,$J,358.3,37062,0)
 ;;=D61.9^^107^1487^28
 ;;^UTILITY(U,$J,358.3,37062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37062,1,3,0)
 ;;=3^Aplastic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,37062,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,37062,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,37063,0)
 ;;=D56.1^^107^1487^34
 ;;^UTILITY(U,$J,358.3,37063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37063,1,3,0)
 ;;=3^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,37063,1,4,0)
 ;;=4^D56.1
 ;;^UTILITY(U,$J,358.3,37063,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,37064,0)
 ;;=C83.79^^107^1487^36
 ;;^UTILITY(U,$J,358.3,37064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37064,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37064,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,37064,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,37065,0)
 ;;=C83.70^^107^1487^37
